Molecular Breast Imaging Market Size, Share, and Industry Analysis By Detector (Single and Dual), By End User (Hospitals & Specialty Clinics and Diagnostic Imaging Centers), and Regional Forecast, 2025-2032

The global molecular breast imaging market is expected to expand significantly, driven by the rising requirement for advanced imaging techniques to diagnose and identify breast cancer efficiently. Through continuous development in MBI technology such as improving resolution, the sensitivity and specification of detecting the disease is supporting market expansion.

• According to the National Center for Biotechnology Information, MBI devices have 90% sensitivity for detection of breast cancer in individuals.
• Molecular breast imaging (MBI) is a diagnostic imaging tool. This device consists of gamma cameras and radiopharmaceuticals to observe the disorder. It is also known as breasts specific gamma imaging (BSGI). Its ingestion is impacted by blood flow and physiological and mitochondrial activity.
• According to the National Center for Biotechnology Information, the incremental cancer detection rate of women with dense breasts is 8.8 per 1,000 women screened using MBI.

Molecular Breast Imaging Market Driver

Rising Incidence of Breast Cancer and Government and Healthcare Investments Enhance Market Growth

Major attribute for market expansion is the increasing prevalence of breast cancer. The rising consciousness regarding the importance of early detection is fueling demand for the devices. Premature detection of the disease is improving survival rate and helps in recovery of an individual, which is supporting the significant demand for imaging devices.

• According to the Susan G. Komen Foundation, the risk of diagnosing an individual to have breast cancer in high breast density is 4-5 times more than the individual with low density.

Furthermore, several governments and healthcare centers are investing huge amounts on research and diagnostic technologies. This financial funding helps manufacturers to develop advanced imaging methods, impelling the market growth. In addition, the organization of several screening programs by various organizations are aiding in promotion of detection and treatment of the disease, driving market growth.

Molecular Breast Imaging Market Restraint

High Cost of MBI Systems and Lack of Standardization Hinder Market Growth

One of the main barriers to the extensive use of MBI is the high cost of the systems. These devices involve specific equipment, radiotracers, and skilled personnel for operation. These features are making the tools pricier than conventional mammography or ultrasound systems. Expensive devices are major constraints for low-income regions where accessibility for availing the facility is limited due to lack of resources and settings.

Furthermore, the inefficient standardization of the devices may hamper the market growth. The devices may vary in the quality and performance of MBI systems designed by several manufacturers may affect the stability and consistency of the outcome. Establishing industry standards for MBI technology is vital to ensure precise and reliable diagnoses across different healthcare settings may obstruct the market growth.

Molecular Breast Imaging Market Opportunity

Integration with Artificial Intelligent (AI) and Advanced Portable and Compact MBI Systems Bolster Market Growth

One of the main opportunities for the market growth is the incorporation of AI and machine learning with the BSGI devices. This integration of advanced technologies is improving diagnostic accuracy, reducing human error, and streamline workflows are bolstering adoption of the system extensively. Furthermore, the development of transportable MBI systems that is affordable and apt for use in numerous medical settings, for instant outpatient clinics and rural areas, could lead to augmented demand for the system. Additionally, the initiation of breast cancer screening programs in emerging markets as well as rising focus on health care infrastructures are propelling market expansion.

Molecular Breast Imaging Market Segmentation

Key Insights

The report covers the following key insights:

• Increasing Prevalence of Breast Cancer, by Key Countries
• Drivers, Restraints, Trends, and Opportunities
• High Investment Strategies Adopted by Key Players
• Consolidated SWOT Analysis of Key Players
• Key Industry Developments (Mergers, Acquisitions, Partnerships)

Analysis by Detector

Based on detector, the molecular breast imaging market is divided into single and dual.

The dual detectors are leading the market owing to high imaging capabilities. This type of device contains of two systems utilizes two gamma cameras to capture images from multiple angels, resulting in higher resolution and more detailed images.

Single detectors tools have conventionally been employed for detection of disease systems. These systems are more cost-effective facilities and involved in early diagnosis of the disorder, allowing this segment to expand significantly.

Analysis by End User

Based on end user, the molecular breast imaging market is divided into hospitals & specialty clinics and diagnostic imaging centers.

The hospitals & specialty clinics are dominating the market caused by their ample healthcare services. They are often a first point of contact for patients for screening and diagnosis of cancer, thus becoming a major end-user of the MBI tools.

Diagnostic imaging centers are expecting significant growth in the market, as they are specialize in diagnosing images and offer a wide range of services. The growing demand for dedicated investigative services has led to the creation of such centers around the world.

Regional Analysis

Based on geography, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America is dominating the market, driven by the high prevalence of breast cancer and the strong healthcare infrastructure. Government initiatives to improve breast cancer detection and their significant investments in cancer research institutes aiding adoption of BSGI systems. The U.S. and Canada are major shareholders in the region of the market due to the increasing acceptance of advanced imaging technologies. The implementation of diagnostic technologies is impelling the adoption of MBI systems in this region.

• Approximately 40-50% of women are detected with dense breasts in their 40-47 ages in the U.S., according to the Susan G. Komen Foundation (komen.org).

Europe is also anticipated to witness considerable growth in the market due to increasing awareness of breast cancer and rising demand for early detection technologies. The growing demand for more effective diagnostic methods with high breast cancer incidence rates is impelling market growth. Germany, France, and the U.K. are major contributors to market growth in the region.

The Asia Pacific region is expected to grow at a fast pace in the market, caused by the rising knowledge among people about breast cancer screening. China, India and Japan are major countries in the region that are supporting market expansion, by providing a favorable environment and adoption of advanced technologies. The increasing healthcare expenditure and improving medical infrastructure in this region is helping market expansion.

Key Players Covered Molecular Breast Imaging Market

The report includes the profiles of the following key players:

• CMR Naviscan Corporation (U.S.)
• SmartBreast Corporation (Taiwan)

Key Industry Developments

• In February 2022, AuntMinnie.com and Delphinus Medical Technologies Inc. re-launched Imaging Leader Community with support from the breast imaging business. Delphinus developed the SoftVue 3D Whole Breast Ultrasound Tomography System to assist in the screening of asymptomatic women with thick tissue.
• In March 2021, Fujifilm Healthcare Europe acquired Hitachi Diagnostic Imaging for EUR 1.3 billion. Through this acquisition they offered comprehensive clinical solutions in CT, MRI, ultrasound, x-ray, women’s health, AI, PACS, and IVD.